COVID-19 Vaccines Report, Jan.15, 2021: CDC Provides Vaccine Allergy Recommendations

The information below is current as of Jan. 15, 2021.  

Distribution and Prioritization  

The Department of State Health Services (DSHS) hosts weekly meetings of the Expert Vaccine Allocation Panel (EVAP). Find details below, and check this DSHS webpage for updates.  

  • CDC Provides Vaccine Allergy Recommendations: The Centers for Disease Control and Prevention (CDC) has published recommendations for people who have severe anaphylaxis after receiving a COVID-19 vaccine. The webpage also includes recommendations for people who have had allergic reactions to other vaccines and for those with other types of allergies. Read more information.
  • What To Do With Potentially Non-Viable Vaccines: DSHS has released guidance for facilities that receive potentially nonviable vaccines, such as shipments that are warm, damaged, or in an otherwise questionable state. Read more information.
  • Effectively Speak to Patients About Vaccines: Do you have patients who are skeptical about the benefits and safety of a COVID-19 vaccine? De Beaumont, a national public health advocacy organization, has published several vaccine communications resources, including a graphic that offers tips on “language that works to improve vaccine acceptance.” Read more information.
  • Building Vaccine Confidence Within the Hispanic Community: The National Hispanic Medical Association has scheduled a virtual briefing on “Building Vaccine Confidence from 6 to 7:15 pm (CT) Wednesday, Jan. 27. The briefing is the fifth part of a series that address lessons learned by physicians and health care professional during the COVID-19 pandemic. Register online.   

Enrollment, Administration, and Reporting                                             

Helpful Links    

Last Updated On

January 15, 2021

Related Content

Coronavirus | Immunization